Nitric oxide pathway, Ca2+, and serotonin content in platelets from patients suffering from chronic daily headache

Cephalalgia

Volumn 19, Issue 9, 1999, Pages 810-816

  Sarchielli, Paola ^{a,b,c,d,e,f,g}   Alberti, A ^a,b,c,d,e,f   Russo, S ^a,b,c,d,e,f   Codini, M ^a,b,c,d,e,f   Panico, R ^a,b,c,d,e,f   Floridi, A ^a,b,c,d,e,f   Gallai, V ^a,b,c,d,e,f  

^a I C S H/N D C N S   (Italy)

^b I C S H N D C N S   (Italy)

^c I C S H/N D C N S   (Italy)

^d I C S H N D C N S   (Italy)

^e I C S H/N D C N S   (Italy)

^f Geriatric Department   (Italy)

^g Neurologic Clinic   (Italy)

Author keywords

Calcium; Chronic daily headache analgesic abuse; Cyclic guanosine monophosphate; Nitric oxide; Platelets; Serotonin

Indexed keywords

ARGININE; CALCIUM ION; COLLAGEN; CYCLIC GMP; NITRIC OXIDE; SEROTONIN; SEROTONIN 2 RECEPTOR;

ADULT; ANALGESIC AGENT ABUSE; ARTICLE; CALCIUM CELL LEVEL; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; FEMALE; FLUORESCENCE POLARIZATION; HEADACHE; HUMAN; HUMAN CELL; MALE; MIGRAINE; RECEPTOR UPREGULATION; SECOND MESSENGER; SEROTONIN RELEASE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0032709173     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1999.1909810.x     Document Type: Article

References (31)

1. Castillo J, Muqoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999;39. In press
2. Scher A, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache 1997;37:330
3. Schnider P, Aull S, Baumgartner C, Marterer A, Wober C, Zeiler K, et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: Five-year follow-up. Cephalalgia 1996;16:481-5
4. Edmeads J. Analgesic-induced headache: An unrecognized epidemic. Headache 1990;30:614-5
5. Rasmussen BK. Epidemiology of headache. Cephalalgia 1991;15:45-68
6. Mathew NT, Stubits E, Nigam MP. Transformation of episodic migraine into daily headache: Analysis of factors. Headache 1992;22:66-8
7. Manzoni GC, Granella F, Sandrini G, Cavallini A, Zanferrari C, Nappi G. Classification of chronic daily headache by International Headache Society criteria: Limits and new proposals. Cephalalgia 1995;15:37-43
8. Pini LA, Bigarelli M, Vitale G, Sternieri E. Headache associated with chronic use of analgesics: A therapeutic approach. Headache 1996;36:443-9
9. Hering R, Gardiner I, Catarci T, Withmarch T, Steiner T, de Belleroche J. Cellular adaptation in migraineurs with chronic daily headache. Cephalalgia 1993;13:261-6
10. D'Andrea G, Cananzi AR, Perini F, Alecci M, Zamberlan F, Hasselmark L, et al. Decreased collagen-induced platelet aggregation and increased platelet arginine levels in migraine: A possible link with the NO pathway. Cephalalgia 1994;14:352-6
11. D'Andrea G, Cananzi AR, Perini F, Hasselmark L. Platelet models and their possible usefulness in the study of migraine pathogenesis. Cephalalgia 1995;15:265-71
12. Gallai V, Floridi A, Mazzotta G, Codini M, Tognoloni M, Ambrosini P, et al. L-arginine/nitric oxide pathway activation in platelets of migraine with and without aura patients. Acta Neurol Scand 1996;94:151-60
13. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: A field study of revised HIS criteria. Neurology 1996;47:871-5
14. Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near daily headaches: Proposed revision of the IHS criteria. Headache 1994;34:1-7
15. Born GVR, Cross MJ. The aggregation of blood platelets. J Physiol 1963;168:178-95
16. 2+ mobilization in human platelets. Br J Pharmacol 1992;106:966-71
17. Grynkiewicz G, Poenie M, Tsien RY. A new generation of calcium indicators with greatly improved fluorescence properties. J Biol Chem 1985:3400-50
18. Radomski MW, Palmer RMJ, Moncada S. L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci 1990;87:5193-7
19. Radomski MW, Palmer RMJ, Moncada S. Characterization of the L-arginine to nitric oxide pathway in human platelets. Br J Pharmacol 1990;101:325-8
20. Poole AW, Watson SP. Regulation of cytosolic calcium by collagen in single human platelets. Br J Pharmacol 1995;115:101-6
21. 2+ concentration. Biochem Biophys Res Commun 1995;215:842-8
22. 2+ release from internal stores in human platelets. Br J Pharmacol 1996;119:1361-6
23. Busse R, Luckhoff A, Basenge E. Endothelium-derived relaxant factor inhibits platelets activation. Naunyn Schmeiders Arch Pharmacol 1987;86:9030-3
24. Sarchielli P, Tognoloni M, Russo S, Feleppa M, Malà M, Sartori M, et al. Variations in the platelet nitric oxide synthase pathway during the ovarian cycle in females affected by menstrual migraine. Cephalalgia 1996;16:450-8
25. Joseph R, Welch KMA, Grunfeld S, Other SB, D'Andrea G. Cytosolic ionized calcium homeostasis in platelets: An abnormal sensitivity to PAF-activation in migraine. Headache 1988;28:398-402
26. Nguyen BL, Saitoh M, Ware A. Interaction of nitric oxide and cGMP with signal trasduction in activated platelets. Am J Physiol 1991;261:1043-52
27. Sarchielli P, Gallai V. Platelet nitric oxide pathway in migraine, EOS. J Immunol Immunopharmacol 1998;18:78-85
28. Srikiatkhachorn A, Anthony M. Platelet serotonin in patients with analgesic-induced headache. Cephalalgia 1996;16:423-6
29. Srikiatkhachorn A, Maneesri S, Govitrapong P, Kasantikul V. Derangement of serotonin system in migrainous patients with analgesic abuse headache: Clues from platelets. Headache 1998;38:43-9
30. Da Prada M, Cesura AM, Launay JM. Platelets as a model for neurons? Experientia 1988;8:7-24
31. Malmgrem R, Hasselmark L. The platelet and the neuron: Two cells in focus in migraine. Cephalalgia 1988;8:7-24